معرفی
Dr. Amie J Goodin is an Assistant Professor in the Department of Pharmaceutical Outcomes and Policy at the University of Florida's College of Pharmacy. She holds dual affiliations with the Center for Drug Evaluation and Safety (CoDES) and leads the Health Services Research track in her department's graduate program. Her research focuses on policy impacts on treatment access for Substance Use Disorders (SUDs), particularly among Medicaid enrollees and pregnant women, integrating mixed-methods approaches. Dr. Goodin completed her PhD at the University of Kentucky and a postdoctoral fellowship at UF, specializing in pharmacoepidemiology and health services research.
Education
- Ph.D. in Public Policy, University of Kentucky (2015)
- M.P.P., University of Kentucky (2009)
- B.S., University of Kentucky (2007)
Research Interests
Dr. Goodin examines how policy changes affect healthcare utilization and disparities, with emphasis on SUD treatment, maternal health, and cannabis use. She develops predictive models using machine learning and electronic health records (EHRs) to address gaps in mental health monitoring and opioid-related outcomes. Her work bridges epidemiology, informatics, and policy analysis to improve health equity.
Recent Article Trends
Her 2025 publications emphasize cannabinoid analysis in maternal health, suicide risk in opioid discontinuation, and cannabis contamination perceptions. 2024 work explores fall risks with depression treatments and machine learning for buprenorphine adherence. These reflect her focus on policy-driven research and translational informatics.
Awards/Grants
- Lead PI for Gator MOMitor maternal health project (Florida Department of Health, 2022–2024)
- NIH-funded study on mental health outcomes of restless legs syndrome treatments (2021–2022)
- Pharmacist opioid disposal system development (Pfizer-funded, 2021)
Advising & Teams
Advisor to graduate students in pharmaceutical outcomes research, with courses on patient safety, research design, and health policy. Leads the Consortium for Medical Marijuana Clinical Outcomes Research's strategy initiatives.
Labs/Teams
Active in the UF Center for Drug Evaluation and Safety, focusing on cannabis clinical outcomes. Collaborates with the Florida Medical Marijuana Use Registry and recovery community centers on implementation science projects.
